COMPL-X Trademark
COMPL-X is a USPTO trademark filed by LAVIPHARM LABORATORIES INC.. Status: Abandoned.
Trademark Facts
| Mark | COMPL-X |
|---|---|
| Serial Number | 76333308 |
| Status | Abandoned |
| Filing Date | 2001-11-02 |
| Mark Type | Word |
| Nice Classes | 007 (Machinery), 009 (Electronics & Software), 040 (Material Treatment), 042 (Software & IT) |
| Owner | LAVIPHARM LABORATORIES INC. |
| Attorney of Record | Glenn A. Gundersen |
| Prosecution Events | 23 |
| Latest Event | MAB6 on 2005-06-08 |
Goods & Services
Custom manufacturing of pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products using supercritical fluid technology; Laboratory equipment for use in researching, developing and manufacturing pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products using supercritical fluid technology; Manufacturing equipment, namely, machines used in researching, developing and manufacturing pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products using supercritical fluid technology; Conducting feasibility studies for others on the use of supercritical fluids in the formulation of pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products; licensing of supercritical fluid technology; developing pharmaceuticals, nutraceuticals, chemicals, proteins, peptides, oligonucleotides, DNA, vaccines, other biotechnology-derived products, and other products for others using supercritical fluid technology